Twist Bioscience Is Maintained at Outperform by Leerink Partners
Ratings actions from Benzinga: GMT) Twist Bioscience Price Target Raised to $190.00/Share From $160.00 by Leerink PartnersRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Twist Bioscience Price Target Raised to $190.00/Share From $160.00 by Leerink PartnersRatings actions from Benzinga